Results 21 to 30 of about 38,648 (233)
Branch retinal vein occlusion associated with quetiapine fumarate [PDF]
, 2011 Background To report a case of branch retinal vein occlusion in a young adult with bipolar mood disorder treated with quetiapine fumarate. Case Presentation A 29 years old gentleman who was taking
Ku Chui Yong +4 more
core +2 more sources
Diagnostics, 2023 Aim: The primary goal of this study was to evaluate the reduction in non-perfusion area and improvement in blood flow as well as the reduction in retinal edema on optical coherence tomography angiography (OCT-A) in patients with retinal vein occlusion ...
Dorota Śpiewak +3 more
doaj +1 more source
Asia-Pacific Journal of Ophthalmology, 2012 Retinal vein occlusions (RVOs) are second to diabetic retinopathy in the prevalence as retinal vascular disorder and are characterized by dilatation of the retinal veins with retinal and subretinal hemorrhages, macular edema, hard retinal exudates, retinal ischemia, and consequent atrophy of the retina and optic nerve.
Jost B, Jonas, Dennis S C, Lam
openaire +2 more sources
Update on Retinal Vein Occlusion
Asia-Pacific Journal of Ophthalmology, 2023 Retinal vein occlusion represents the second leading cause of retinal vascular disorders, with a uniform sex distribution worldwide. A thorough evaluation of cardiovascular risk factors is required to correct possible comorbidities. The diagnosis and management of retinal vein occlusion have changed tremendously in the last 30 years, but the assessment
Romano, Francesco +14 more
openaire +3 more sources
MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT OF RETINAL VEIN OCCLUSION
Сибирский научный медицинский журнал, 2019 Retinal vein occlusion is the one of the most common diseases, which amounts to 60 % of all acute vascular ocular pathology, and takes second place in the severity of retinal lesions and prognosis after diabetic retinopathy.
P. L. Volodin +2 more
doaj +1 more source
Widening use of dexamethasone implant for the treatment of macular edema [PDF]
, 2017 Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T. +9 more
core +2 more sources
association oF systemic Diseases witH retinal vein occlusive Disease
Journal of Nepal Medical Association, 2006 Retinal vein occlusion (RVO) is the second commonest vascular disease of the eye, second only to Diabetic Retinopathy. The association of the retinal vein occlusion with other systemic disease likes hypertension, diabetes mellitus and others has been ...
Rajesh Kishor Shrestha +3 more
doaj +1 more source
Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report [PDF]
, 2016 Background Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon ...
AGOSTINELLI, Enzo +6 more
core +1 more source
ROLE OF BEVACIZUMAB FOR PREVENTION OF NEOVASCULAR GLAUCOMA IN ACUTE RETINAL VEIN OCCLUSION [PDF]
Journal of University Medical & Dental College, 2018 : There is a possibility of developing neovascular glaucoma in ischemic type of retinal vein occlusion. Purpose of the study is to determine the role of anti VEGF agent bevacizumab for prevention of neovascular glaucoma in ischemic type of retinal vein ...
Bassam Mubarik , Adeen Akram
doaj +1 more source
Journal of Ophthalmology, 2015 Branch retinal vein occlusion induces complex biological processes in the retina that are generated by a multitude of interacting proteins. These proteins and their posttranslational modifications can effectively be studied using modern proteomic ...
Lasse Jørgensen Cehofski +5 more
doaj +1 more source